Hummingbird Bioscience

📍 Singapore, Singapore🗓 Founded 2015👥 91 employees💰 Last funded May 2020
Biotechnology Research🌐 hummingbirdbioscience.com
Website LinkedIn
Hummingbird Bioscience is a precision biotherapeutics company discovering and developing transformative biologics for hard-to-treat diseases. The Hummingbird Bioscience model combines computational and systems biology, and wet lab drug discovery in a multi-disciplinary, collaborative environment spanning initial discovery through clinical development. We harness this integrated approach across target identification and patient selection, enabling our team to increase the efficiency of translating novel scientific insights while reducing the inherent risk in drug discovery and development. At Hummingbird Bioscience, our commitment to rigorous science, teamwork, and intellectual integrity underpins our passion to accelerate the journey of new drugs from concept to clinic. Sign up for our updates here: https://bit.ly/HMBDNews
6
Total investors
4
Early stage
1
Mid stage
1
Late stage
2015
Founded

Investors

6 investors
All
Early stage
Mid stage
Late stage
Investor geography4 countries
Singapore
3
China
1
South Korea
1
India
1
Investor activity2015–2020 · investors recorded per year
201542019120201
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Hummingbird Bioscience?
Hummingbird Bioscience has 6 investors on record on gritt.io, including 4 early-stage backers, 1 mid-stage and 1 late-stage investors.
When did Hummingbird Bioscience last raise funding?
The most recent investment in Hummingbird Bioscience recorded on gritt.io was in May 2020.
When was Hummingbird Bioscience founded?
Hummingbird Bioscience was founded in 2015.
What industry is Hummingbird Bioscience in?
Hummingbird Bioscience operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Hummingbird Bioscience based?
Hummingbird Bioscience is headquartered in Singapore, Singapore.